Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Rituxan rituximab anti-CD20 antibody regulatory update

The Appraisals Committee of the U.K.'s National Institute for Clinical Excellence released a preliminary appraisal document recommending use of rituximab in combination with CHOP

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE